Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine.

The Ebola virus is transmitted by direct contact with bodily fluids of infected individuals, eliciting death rates as high as 90% among infected humans. Currently, replication defective adenovirus-based Ebola vaccine is being studied in a phase I clinical trial. Another Ebola vaccine, based on an at...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jason S Richardson, Michel K Yao, Kaylie N Tran, Maria A Croyle, James E Strong, Heinz Feldmann, Gary P Kobinger
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science (PLoS) 2009-01-01
Col·lecció:PLoS ONE
Accés en línia:http://europepmc.org/articles/PMC2669164?pdf=render
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars